These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


552 related items for PubMed ID: 16264406

  • 1. Activity of estradiol and selective estrogen receptor modulators in the mouse N20.1 oligodendrocyte/astrocytes cell line.
    Guzmán CB, Deighton-Collins S, Martinez A, Kleerekoper M, Zhao C, Benjamins JA, Skafar DF.
    Neuro Endocrinol Lett; 2005 Oct; 26(5):526-32. PubMed ID: 16264406
    [Abstract] [Full Text] [Related]

  • 2. Agonist activity of the 3-hydroxy metabolites of tibolone through the oestrogen receptor in the mouse N20.1 oligodendrocyte cell line and normal human astrocytes.
    Guzmán CB, Zhao C, Deighton-Collins S, Kleerekoper M, Benjamins JA, Skafar DF.
    J Neuroendocrinol; 2007 Dec; 19(12):958-65. PubMed ID: 18001325
    [Abstract] [Full Text] [Related]

  • 3. Estrogen and the selective estrogen receptor modulator (SERM) protection against cell death in estrogen receptor alpha and beta expressing U2OS cells.
    Kallio A, Guo T, Lamminen E, Seppänen J, Kangas L, Väänänen HK, Härkönen P.
    Mol Cell Endocrinol; 2008 Jul 16; 289(1-2):38-48. PubMed ID: 18455292
    [Abstract] [Full Text] [Related]

  • 4. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.
    Gougelet A, Mueller SO, Korach KS, Renoir JM.
    J Steroid Biochem Mol Biol; 2007 May 16; 104(3-5):110-22. PubMed ID: 17478088
    [Abstract] [Full Text] [Related]

  • 5. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.
    Chen B, Gajdos C, Dardes R, Kidwai N, Johnston SR, Dowsett M, Jordan VC.
    Int J Oncol; 2005 Aug 16; 27(2):327-35. PubMed ID: 16010412
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta.
    Escande A, Pillon A, Servant N, Cravedi JP, Larrea F, Muhn P, Nicolas JC, Cavaillès V, Balaguer P.
    Biochem Pharmacol; 2006 May 14; 71(10):1459-69. PubMed ID: 16554039
    [Abstract] [Full Text] [Related]

  • 7. Identification of coregulators influenced by estrogen receptor subtype specific binding of the ER antagonists 4-hydroxytamoxifen and fulvestrant.
    Evers NM, Wang S, van den Berg JH, Houtman R, Melchers D, de Haan LH, Ederveen AG, Groten JP, Rietjens IM.
    Chem Biol Interact; 2014 Sep 05; 220():222-30. PubMed ID: 25014417
    [Abstract] [Full Text] [Related]

  • 8. Regulation of estrogen target genes and growth by selective estrogen-receptor modulators in endometrial cancer cells.
    Dardes RC, Schafer JM, Pearce ST, Osipo C, Chen B, Jordan VC.
    Gynecol Oncol; 2002 Jun 05; 85(3):498-506. PubMed ID: 12051881
    [Abstract] [Full Text] [Related]

  • 9. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H, Ancelin M, Lardeux B, Milanini J, Perrot-Applanat M.
    Cancer Res; 2002 Sep 01; 62(17):4977-84. PubMed ID: 12208749
    [Abstract] [Full Text] [Related]

  • 10. Oestrogens and selective oestrogen receptor (ER) modulators regulate EGF receptor gene expression through human ER alpha and beta subtypes via an Sp1 site.
    Salvatori L, Pallante P, Ravenna L, Chinzari P, Frati L, Russo MA, Petrangeli E.
    Oncogene; 2003 Jul 31; 22(31):4875-81. PubMed ID: 12894229
    [Abstract] [Full Text] [Related]

  • 11. Transcriptional activity of estrogen receptors ERalpha and ERbeta in the EtC.1 cerebellar granule cell line.
    Gottfried-Blackmore A, Croft G, McEwen BS, Bulloch K.
    Brain Res; 2007 Dec 31; 1186():41-7. PubMed ID: 18021758
    [Abstract] [Full Text] [Related]

  • 12. Expression and role of estrogen receptor alpha and beta in medullary thyroid carcinoma: different roles in cancer growth and apoptosis.
    Cho MA, Lee MK, Nam KH, Chung WY, Park CS, Lee JH, Noh T, Yang WI, Rhee Y, Lim SK, Lee HC, Lee EJ.
    J Endocrinol; 2007 Nov 31; 195(2):255-63. PubMed ID: 17951536
    [Abstract] [Full Text] [Related]

  • 13. Phenytoin is an estrogen receptor α-selective modulator that interacts with helix 12.
    Fadiel A, Song J, Tivon D, Hamza A, Cardozo T, Naftolin F.
    Reprod Sci; 2015 Feb 31; 22(2):146-55. PubMed ID: 25258361
    [Abstract] [Full Text] [Related]

  • 14. Estrogen receptor (ER)-mediated transcriptional regulation of the human corticotropin-releasing hormone-binding protein promoter: differential effects of ERalpha and ERbeta.
    van de Stolpe A, Slycke AJ, Reinders MO, Zomer AW, Goodenough S, Behl C, Seasholtz AF, van der Saag PT.
    Mol Endocrinol; 2004 Dec 31; 18(12):2908-23. PubMed ID: 15345745
    [Abstract] [Full Text] [Related]

  • 15. Multiple transcription factor elements collaborate with estrogen receptor alpha to activate an inducible estrogen response element in the NKG2E gene.
    Levy N, Zhao X, Tang H, Jaffe RB, Speed TP, Leitman DC.
    Endocrinology; 2007 Jul 31; 148(7):3449-58. PubMed ID: 17395694
    [Abstract] [Full Text] [Related]

  • 16. Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors.
    Klinge CM, Jernigan SC, Mattingly KA, Risinger KE, Zhang J.
    J Mol Endocrinol; 2004 Oct 31; 33(2):387-410. PubMed ID: 15525597
    [Abstract] [Full Text] [Related]

  • 17. Prenylation inhibitors stimulate both estrogen receptor alpha transcriptional activity through AF-1 and AF-2 and estrogen receptor beta transcriptional activity.
    Cestac P, Sarrabayrouse G, Médale-Giamarchi C, Rochaix P, Balaguer P, Favre G, Faye JC, Doisneau-Sixou S.
    Breast Cancer Res; 2005 Oct 31; 7(1):R60-70. PubMed ID: 15642170
    [Abstract] [Full Text] [Related]

  • 18. Estrogen receptor beta activates the human retinoic acid receptor alpha-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen.
    Zou A, Marschke KB, Arnold KE, Berger EM, Fitzgerald P, Mais DE, Allegretto EA.
    Mol Endocrinol; 1999 Mar 31; 13(3):418-30. PubMed ID: 10076999
    [Abstract] [Full Text] [Related]

  • 19. Estrogens activate bone morphogenetic protein-2 gene transcription in mouse mesenchymal stem cells.
    Zhou S, Turgeman G, Harris SE, Leitman DC, Komm BS, Bodine PV, Gazit D.
    Mol Endocrinol; 2003 Jan 31; 17(1):56-66. PubMed ID: 12511606
    [Abstract] [Full Text] [Related]

  • 20. Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β.
    Rossi V, Bellastella G, De Rosa C, Abbondanza C, Visconti D, Maione L, Chieffi P, Della Ragione F, Prezioso D, De Bellis A, Bellastella A, Sinisi AA.
    J Cell Physiol; 2011 May 31; 226(5):1334-9. PubMed ID: 20945400
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 28.